Dr. Ehlinger also announced that the department will expand the program by allowing medical cannabis topicals, including patches, lotions, creams, gels, and ointments. Topicals have been shown to be a safe form of administering medical cannabis.
Last year, intractable pain was added to the Minnesota
program, significantly increasing patient participation. The program — one of the most limited in the nation — had suffered from a lack of patient participation due to few qualifying conditions. The Commissioner reviewed a total of nine petitions requesting program expansion. While MPP wishes they had all been adopted, adding PTSD will help many hundreds of patients and is a significant victory.